ASCO 2022 Conference Coverage
Playback speed
10 seconds
Lecture Summary - ASCO 2022 Phase 2 Study of Lasofoxifene + Abemaciclib for Treating Pre-/Post-Menopausal Women With Locally Advanced/Metastatic ER+/HER2- BC and an ESR1 Mutation After Progression on Prior Therapies
By
ASCO 2022 Conference Coverage
FEATURING
Senthil Damodaran
By
ASCO 2022 Conference Coverage
FEATURING
Senthil Damodaran
8 views
June 30, 2022
Login to view comments.
Click here to Login
Breast